Bulletin
Investor Alert

Horizon Therapeutics PLC

NAS: HZNP

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

May 20, 2022, 5:20 p.m.

/zigman2/quotes/206690250/composite

$

90.35

Change

0.00 0.00%

Volume

Volume 231,939

Quotes are delayed by 20 min

/zigman2/quotes/206690250/composite

Previous close

$ 89.34

$ 90.35

Change

+1.01 +1.13%

Day low

Day high

$87.88

$90.87

Open

52 week low

52 week high

$82.51

$120.54

Open

Pascale Witz

Founder of PWH Advisors, Pascale Witz is a French businessperson who has been at the head of 5 different companies and presently occupies the position of Chairman at RTI Surgical, Inc., President & Chief Executive Officer of PWH Advisors and Senior Advisor at Arsenal Capital Management LP. Ms. Witz is also on the board of 12 other companies.

Pascale Witz previously occupied the position of Executive VP-Diabetes & Cardiovascular at Sanofi, President & Chief Executive Officer of GE Healthcare Medical Diagnostics, President & CEO-Medical Diagnostics at GE Healthcare Ltd. (United Kingdom), President & GM-Interventional Radiology at GE Healthcare IVD Technologies and Marketing Manager at Becton Dickinson France SAS.

She received a graduate degree from Institut National des Sciences Appliquées de Lyon and an MBA from INSEAD.

Transactions

Date Shares Transaction Value
04/29/2022 1,658   Derivative/Non-derivative trans. at $98.56 per share. 163,413
04/29/2022 4,223   Derivative/Non-derivative trans. at $0 per share. 0
04/30/2021 4,357   Derivative/Non-derivative trans. at $94.62 per share. 412,260
04/30/2021 11,098   Derivative/Non-derivative trans. at $0 per share. 0
08/02/2020 3,221   Derivative/Non-derivative trans. at $61.19 per share. 197,093
08/02/2020 8,204   Derivative/Non-derivative trans. at $0 per share. 0
05/02/2020 6,041   Derivative/Non-derivative trans. at $35.62 per share. 215,181
05/02/2020 15,390   Derivative/Non-derivative trans. at $0 per share. 0
08/02/2019 3,220   Derivative/Non-derivative trans. at $24.64 per share. 79,341
08/02/2019 8,203   Derivative/Non-derivative trans. at $0 per share. 0
05/03/2019 6,014   Derivative/Non-derivative trans. at $26.54 per share. 159,612
05/03/2019 15,320   Derivative/Non-derivative trans. at $0 per share. 0
08/02/2018 2,213   Derivative/Non-derivative trans. at $18.18 per share. 40,233
08/02/2018 8,203   Derivative/Non-derivative trans. at $0 per share. 0

Officers and Executives

Mr. Timothy P. Walbert
Chairman, President & Chief Executive Officer
Mr. Aaron L. Cox
Chief Financial Officer & Executive Vice President
Dr. Karin Rosen
Chief Scientific Officer
Dr. Elizabeth H. Z. Thompson
Executive Vice President-Research & Development
Dr. Jeffrey W. Sherman
Chief Medical Officer & Executive Vice President
Mr. Michael A. DesJardin
Executive VP-Technical Operations & Quality
Dr. Jeffrey D. Kent
Executive VP-Medical Affairs & Outcomes Research
Mr. Andy Pasternak
Chief Strategy Officer & Executive Vice President
Ms. Holly Copeland
Senior Director-Corporate Social Responsibility
Ms. Marilyn Vetter
Group Vice President-Market Access
Mr. Vikram Karnani
President-International & Executive Vice President
Mr. Miles W. McHugh
Chief Accounting Officer & Senior Vice President
Ms. Tina Ventura
Chief Investor Relations Officer & Senior VP
Ms. Jane Gonnerman
Chief of Staff & Group Vice President-Development
Ms. Irina P. Konstantinovsky
EVP, Chief Human Resources & Diversity Officer
Mr. David Caraher
Secretary
Mr. Sean M. Clayton
Executive Vice President & General Counsel
Dr. Susan Mahony
Independent Director
Mr. Michael G. Grey
Lead Independent Director
Dr. Jeff Himawan
Independent Director
Mr. William Francis Daniel
Independent Director
Ms. Pascale Witz
Independent Director
Dr. James Samuel Shannon
Independent Director
Mr. H. Thomas Watkins
Independent Director
Mr. Gino Santini
Independent Director
Link to MarketWatch's Slice.